sjsa 1 Search Results


96
ATCC sjsa 1 cells
Sjsa 1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sjsa 1 cells/product/ATCC
Average 96 stars, based on 1 article reviews
sjsa 1 cells - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

94
ATCC human osteosarcoma line
(A) Consistent with our previously data , Western blotting showed an increase in p53 levels within 4 hours exposure to Nutlin-3a in p202, p218, and IMR32 cells, confirming that the p53 signaling pathway is active in our system. (B) Apoptosis induction was tested in five established neuroblastoma lines (JF, IMR32), early passage neuroblastoma tumor cultures (p202, p218, H), and four non-neuroblastoma human solid tumors including colorectal (HCT116), breast (MCF7) and <t>osteosarcoma</t> (SJSA-1). SJSA-1 line differs by the level of MDM2 expression, being amplified 25 fold. A p53 mutant neuroblastoma line (SJ3-12), which lacks part of the DNA binding domain, was used as control. Proliferating cells were treated with Nutlin-3a for 24 hours and TdT-positive fraction was measured by flow cytometry. (C) Pathways enriched upon Nutlin-3a treatment: p53 signaling (GSEA ID: M6370), DNA damage (GSEA ID: M8378), and chemotherapy response (bleo_human_lymph) genes. Vertical columns separate Nutlin-3a versus Nutlin-3b at 3, 8, and 16 hours, horizontal rows indicate genes.
Human Osteosarcoma Line, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma line/product/ATCC
Average 94 stars, based on 1 article reviews
human osteosarcoma line - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
Fuxiang Biotechnology Co Ltd sjsa-1 cells
(A) Consistent with our previously data , Western blotting showed an increase in p53 levels within 4 hours exposure to Nutlin-3a in p202, p218, and IMR32 cells, confirming that the p53 signaling pathway is active in our system. (B) Apoptosis induction was tested in five established neuroblastoma lines (JF, IMR32), early passage neuroblastoma tumor cultures (p202, p218, H), and four non-neuroblastoma human solid tumors including colorectal (HCT116), breast (MCF7) and <t>osteosarcoma</t> (SJSA-1). SJSA-1 line differs by the level of MDM2 expression, being amplified 25 fold. A p53 mutant neuroblastoma line (SJ3-12), which lacks part of the DNA binding domain, was used as control. Proliferating cells were treated with Nutlin-3a for 24 hours and TdT-positive fraction was measured by flow cytometry. (C) Pathways enriched upon Nutlin-3a treatment: p53 signaling (GSEA ID: M6370), DNA damage (GSEA ID: M8378), and chemotherapy response (bleo_human_lymph) genes. Vertical columns separate Nutlin-3a versus Nutlin-3b at 3, 8, and 16 hours, horizontal rows indicate genes.
Sjsa 1 Cells, supplied by Fuxiang Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sjsa-1 cells/product/Fuxiang Biotechnology Co Ltd
Average 90 stars, based on 1 article reviews
sjsa-1 cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GemPharmatech Co Ltd sjsa-1 tumor cells
(A) Consistent with our previously data , Western blotting showed an increase in p53 levels within 4 hours exposure to Nutlin-3a in p202, p218, and IMR32 cells, confirming that the p53 signaling pathway is active in our system. (B) Apoptosis induction was tested in five established neuroblastoma lines (JF, IMR32), early passage neuroblastoma tumor cultures (p202, p218, H), and four non-neuroblastoma human solid tumors including colorectal (HCT116), breast (MCF7) and <t>osteosarcoma</t> (SJSA-1). SJSA-1 line differs by the level of MDM2 expression, being amplified 25 fold. A p53 mutant neuroblastoma line (SJ3-12), which lacks part of the DNA binding domain, was used as control. Proliferating cells were treated with Nutlin-3a for 24 hours and TdT-positive fraction was measured by flow cytometry. (C) Pathways enriched upon Nutlin-3a treatment: p53 signaling (GSEA ID: M6370), DNA damage (GSEA ID: M8378), and chemotherapy response (bleo_human_lymph) genes. Vertical columns separate Nutlin-3a versus Nutlin-3b at 3, 8, and 16 hours, horizontal rows indicate genes.
Sjsa 1 Tumor Cells, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sjsa-1 tumor cells/product/GemPharmatech Co Ltd
Average 90 stars, based on 1 article reviews
sjsa-1 tumor cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies sjsa-1 cells
(A) Consistent with our previously data , Western blotting showed an increase in p53 levels within 4 hours exposure to Nutlin-3a in p202, p218, and IMR32 cells, confirming that the p53 signaling pathway is active in our system. (B) Apoptosis induction was tested in five established neuroblastoma lines (JF, IMR32), early passage neuroblastoma tumor cultures (p202, p218, H), and four non-neuroblastoma human solid tumors including colorectal (HCT116), breast (MCF7) and <t>osteosarcoma</t> (SJSA-1). SJSA-1 line differs by the level of MDM2 expression, being amplified 25 fold. A p53 mutant neuroblastoma line (SJ3-12), which lacks part of the DNA binding domain, was used as control. Proliferating cells were treated with Nutlin-3a for 24 hours and TdT-positive fraction was measured by flow cytometry. (C) Pathways enriched upon Nutlin-3a treatment: p53 signaling (GSEA ID: M6370), DNA damage (GSEA ID: M8378), and chemotherapy response (bleo_human_lymph) genes. Vertical columns separate Nutlin-3a versus Nutlin-3b at 3, 8, and 16 hours, horizontal rows indicate genes.
Sjsa 1 Cells, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sjsa-1 cells/product/Federation of European Neuroscience Societies
Average 90 stars, based on 1 article reviews
sjsa-1 cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics human os cell lines (u2s2, saos-2, sjsa-1, and hos)
The qPCR result of seven lncRNAs in five OS highly <t>metastasis</t> and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.
Human Os Cell Lines (U2s2, Saos 2, Sjsa 1, And Hos), supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human os cell lines (u2s2, saos-2, sjsa-1, and hos)/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
human os cell lines (u2s2, saos-2, sjsa-1, and hos) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Harlan Laboratories sjsa-1 osteosarcoma cells
The qPCR result of seven lncRNAs in five OS highly <t>metastasis</t> and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.
Sjsa 1 Osteosarcoma Cells, supplied by Harlan Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sjsa-1 osteosarcoma cells/product/Harlan Laboratories
Average 90 stars, based on 1 article reviews
sjsa-1 osteosarcoma cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
WuXi AppTec sjsa-1 cells
The qPCR result of seven lncRNAs in five OS highly <t>metastasis</t> and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.
Sjsa 1 Cells, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sjsa-1 cells/product/WuXi AppTec
Average 90 stars, based on 1 article reviews
sjsa-1 cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

N/A
SJSA-1 (NFkB) Luciferase cell line is transformed from SJSA-1 cell, expressing the firefly luciferase gene. The cell constitutively express Luciferase.
  Buy from Supplier

N/A
The SJSA-1 cell line (formerly OsA-CL) was established in 1982 from the primary tumor of a patient diagnosed with primitive multipotential sarcoma of the femur.
  Buy from Supplier

N/A
Tissue: Bone. SJSA-1 cells also exhibit a 15 fold amplification of the gli proto-oncogene.
  Buy from Supplier

N/A
SJSA-1 Cells Complete Medium is a cells complete medium from Innovative Research, supplied as a ready-to-use liquid. More Details: Formulation: RPMI-1640 + 10%FBS + 1%P/S Bacterial detection: Negative Fungal detection: Negative Mycoplasma detection: Negative Endotoxin
  Buy from Supplier

Image Search Results


(A) Consistent with our previously data , Western blotting showed an increase in p53 levels within 4 hours exposure to Nutlin-3a in p202, p218, and IMR32 cells, confirming that the p53 signaling pathway is active in our system. (B) Apoptosis induction was tested in five established neuroblastoma lines (JF, IMR32), early passage neuroblastoma tumor cultures (p202, p218, H), and four non-neuroblastoma human solid tumors including colorectal (HCT116), breast (MCF7) and osteosarcoma (SJSA-1). SJSA-1 line differs by the level of MDM2 expression, being amplified 25 fold. A p53 mutant neuroblastoma line (SJ3-12), which lacks part of the DNA binding domain, was used as control. Proliferating cells were treated with Nutlin-3a for 24 hours and TdT-positive fraction was measured by flow cytometry. (C) Pathways enriched upon Nutlin-3a treatment: p53 signaling (GSEA ID: M6370), DNA damage (GSEA ID: M8378), and chemotherapy response (bleo_human_lymph) genes. Vertical columns separate Nutlin-3a versus Nutlin-3b at 3, 8, and 16 hours, horizontal rows indicate genes.

Journal: PLoS ONE

Article Title: A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma

doi: 10.1371/journal.pone.0079843

Figure Lengend Snippet: (A) Consistent with our previously data , Western blotting showed an increase in p53 levels within 4 hours exposure to Nutlin-3a in p202, p218, and IMR32 cells, confirming that the p53 signaling pathway is active in our system. (B) Apoptosis induction was tested in five established neuroblastoma lines (JF, IMR32), early passage neuroblastoma tumor cultures (p202, p218, H), and four non-neuroblastoma human solid tumors including colorectal (HCT116), breast (MCF7) and osteosarcoma (SJSA-1). SJSA-1 line differs by the level of MDM2 expression, being amplified 25 fold. A p53 mutant neuroblastoma line (SJ3-12), which lacks part of the DNA binding domain, was used as control. Proliferating cells were treated with Nutlin-3a for 24 hours and TdT-positive fraction was measured by flow cytometry. (C) Pathways enriched upon Nutlin-3a treatment: p53 signaling (GSEA ID: M6370), DNA damage (GSEA ID: M8378), and chemotherapy response (bleo_human_lymph) genes. Vertical columns separate Nutlin-3a versus Nutlin-3b at 3, 8, and 16 hours, horizontal rows indicate genes.

Article Snippet: JF (ATCC), IMR32 (ATCC), LAN5 (LS Metelitsa, Houston TX), and LAN1 (ATCC) human NB lines were maintained in RPMI 1640; human colorectal cancer cell line, HCT 116 (ATCC), and human breast cancer cell line, MCF7 (ATCC), in McCoy’s 5A and DMEM plus 1% insulin respectively; human osteosarcoma line, SJSA-1 (ATCC), in RPMI 1640 medium with 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate; primary neuroblastoma lines (p202, p218, pH) (Texas Children’s Cancer Center, Houston, TX) and CHLA255 line (LS Metelitsa) in IMDM with 20% FBS and 0.1% ITS.

Techniques: Western Blot, Expressing, Amplification, Mutagenesis, Binding Assay, Control, Flow Cytometry

The qPCR result of seven lncRNAs in five OS highly metastasis and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.

Journal: Cancer Management and Research

Article Title: A Novel Predictive Model Associated with Osteosarcoma Metastasis

doi: 10.2147/CMAR.S332387

Figure Lengend Snippet: The qPCR result of seven lncRNAs in five OS highly metastasis and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.

Article Snippet: Highly metastasis human OS cell lines (MNNG) and weakly metastasis human OS cell lines (U2S2, SAOS-2, SJSA-1, and HOS) were purchased from iCell (Shanghai, China).

Techniques: